Literature DB >> 26152741

Moving Beyond "Lumpology": PET/CT Imaging of Pheochromocytoma and Paraganglioma.

Michael S Hofman1, Rodney J Hicks1.   

Abstract

High somatostatin receptor expression on the cell membrane of succinate dehydrogenase mutation-related pheochromocytoma and paraganglioma provides a potential target for imaging and therapy. (68)Ga-DOTATATE positron emission PET/CT may represent a new gold standard for staging pheochromocytoma/paraganglioma and have future therapeutic implications. ©2015 American Association for Cancer Research.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26152741     DOI： 10.1158/1078-0432.CCR-15-1073

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  10 in total

1.  Molecular Imaging in the Era of Precision Medicine: Paraganglioma as a Template for Understanding Multiple Levels of Analysis.

Authors:  David Taïeb; Dimitris Visvikis; Rodney J Hicks; Karel Pacak
Journal:  J Nucl Med       Date:  2020-03-13       Impact factor: 10.057

Review 2.  From Diagnosis to Therapy-PET Imaging for Pheochromocytomas and Paragangliomas.

Authors:  Hiren V Patel; Arnav Srivastava; Murray D Becker; Toni Beninato; Amanda M Laird; Eric A Singer
Journal:  Curr Urol Rep       Date:  2021-01-06       Impact factor: 3.092

Review 3.  Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups.

Authors:  David Taïeb; Abhishek Jha; Giorgio Treglia; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2019-11       Impact factor: 5.678

4.  Functional Imaging Signature of Patients Presenting with Polycythemia/Paraganglioma Syndromes.

Authors:  Ingo Janssen; Clara C Chen; Zhenping Zhuang; Corina M Millo; Katherine I Wolf; Alexander Ling; Frank I Lin; Karen T Adams; Peter Herscovitch; Richard A Feelders; Antonio T Fojo; David Taieb; Electron Kebebew; Karel Pacak
Journal:  J Nucl Med       Date:  2017-03-23       Impact factor: 10.057

5.  PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma.

Authors:  Ingo Janssen; Clara C Chen; Corina M Millo; Alexander Ling; David Taieb; Frank I Lin; Karen T Adams; Katherine I Wolf; Peter Herscovitch; Antonio T Fojo; Inga Buchmann; Electron Kebebew; Karel Pacak
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-21       Impact factor: 9.236

6.  Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.

Authors:  Aurélien Archier; Arthur Varoquaux; Philippe Garrigue; Marion Montava; Carole Guerin; Sophie Gabriel; Eva Beschmout; Isabelle Morange; Nicolas Fakhry; Frédéric Castinetti; Frédéric Sebag; Anne Barlier; Anderson Loundou; Benjamin Guillet; Karel Pacak; David Taïeb
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-05       Impact factor: 9.236

7.  Radiopharmaceuticals in paraganglioma imaging: too many members on board?

Authors:  David Taïeb; Rodney J Hicks; Karel Pacak
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-13       Impact factor: 9.236

8.  (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.

Authors:  Chian A Chang; David A Pattison; Richard W Tothill; Grace Kong; Tim J Akhurst; Rodney J Hicks; Michael S Hofman
Journal:  Cancer Imaging       Date:  2016-08-17       Impact factor: 3.909

9.  Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15-19, 2016; Tübingen, Germany.

Authors:  D L Bailey; B J Pichler; B Gückel; H Barthel; A J Beer; R Botnar; R Gillies; V Goh; M Gotthardt; R J Hicks; R Lanzenberger; C la Fougere; M Lentschig; S G Nekolla; T Niederdraenk; K Nikolaou; J Nuyts; D Olego; K Åhlström Riklund; A Signore; M Schäfers; V Sossi; M Suminski; P Veit-Haibach; L Umutlu; M Wissmeyer; T Beyer
Journal:  Mol Imaging Biol       Date:  2016-10       Impact factor: 3.488

Review 10.  Functional Imaging of Paragangliomas with an Emphasis on Von Hippel-Lindau-Associated Disease: A Mini Review.

Authors:  Ioannis Ilias; Georgios Meristoudis
Journal:  J Kidney Cancer VHL       Date:  2017-09-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.